Format

Send to

Choose Destination
Eur J Immunol. 2007 Nov;37 Suppl 1:S116-23.

Regulatory T cells - a brief history and perspective.

Author information

1
Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan. shimon@frontier.kyoto-u.ac.jp

Abstract

It is now widely accepted that the normal immune system harbors a regulatory T-cell population specialized for immune suppression. It was found initially that some CD4(+) T cells in normal animals were capable of suppressing autoimmunity. Characterization of this autoimmune-suppressive CD4(+) T cell population revealed that they constitutively expressed the CD25 molecule, which made it possible to distinguish them from other T cells, delineate their developmental pathways, in particular their thymic development, and characterize their potent in vivo and in vitro immunosuppressive activity. The marker also helped to identify human regulatory T cells with similar functional and phenotypic characteristics. Recent studies have shown that CD25(+)CD4(+) regulatory T cells specifically express the transcription factor Foxp3. Genetic anomaly of Foxp3 causes autoimmune and inflammatory disease in rodents and humans through affecting the development and function of CD25(+)CD4(+) regulatory T cells. These findings at the cellular and molecular levels altogether provide firm evidence for Foxp3(+)CD25(+)CD4(+) regulatory T cells as an indispensable cellular constituent of the normal immune system and for their crucial roles in establishing and maintaining immunologic self-tolerance and immune homeostasis. They can be exploited for clinical use to treat immunological diseases and control physiological and pathological immune responses.

PMID:
17972355
DOI:
10.1002/eji.200737593
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center